Doxorubicin-isoniazid conjugate regulates immune response and tumor microenvironment to enhance cancer therapy
Chan Jin, Jingbo Li, Xiaoguang Yang, Shuang Zhou, Chang Li, Yu Jiang, Zhaomeng Wang, Dun Wang, Zhonggui He, Yiguo Jiang, Yongjun Wang
Topics & Concepts
Cancer researchPharmacologyImmune systemTumor microenvironmentCancer immunotherapyDoxorubicinImmune checkpointImmunotherapyMedicineChemistryImmunologyChemotherapyInternal medicineCancer Immunotherapy and BiomarkersNanoplatforms for cancer theranosticsAdenosine and Purinergic Signaling